Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. STYRAX LIFE SCIENCES PRIVATE LIMITED
483
•STYRAX LIFE SCIENCES PRIVATE LIMITED•June 7, 2024

FDA 483 - STYRAX LIFE SCIENCES PRIVATE LIMITED - June 07, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Form 483 was issued to Styrax Life Sciences Pvt. Ltd., an API Intermediate Manufacturer in Anakapalli, following an inspection from June 3-7, 2024. The inspection revealed significant deficiencies in laboratory controls, specifically the failure to validate analytical methods for raw materials, in-process, and finished product testing. Additionally, the firm failed to perform identity testing on incoming raw materials used in manufacturing.

Company
STYRAX LIFE SCIENCES PRIVATE LIMITED
Inspection Date
June 7, 2024
Product Type
Drugs
Office
Office of Biological Products Operations - Division I
Person
  • Dogbeda F. Mackenzie
Open in Dashboard

ID · d492609f-652b-4b71-9418-abe4d361d047

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.